Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01698008 · ClinicalTrials.gov registry record · NA
Effect of Mobile Phone Telemedicine on Diabetes Care
A NA study, sponsored by University of Nebraska.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT01698008: Completed NA study, sponsored by University of Nebraska.
NCT01698008 is a NA study that has completed, run by University of Nebraska. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01698008, a NA study, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
Adult patients with diabetes on insulin are eligible for the study. They will be randomized to a group using standard of care communication and a group using an I phone intervention.
Primary Outcome
Satisfaction and usability was evaluated with a survey for those subjects who used the mobile phone application at the 3 and 6 months period.
Interventions
- OTHER Diabetes Doctor Mobile app
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2012-01-28 |
| Est. Completion | 2013-09-25 |
| Phase | NA |
What the finished NCT01698008 record still lists
NCT01698008 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Diabetes Doctor Mobile app is the first listed.
NCT01698008 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01698008 about?
NCT01698008 is a clinical study titled "Effect of Mobile Phone Telemedicine on Diabetes Care". Adult patients with diabetes on insulin are eligible for the study. They will be randomized to a group using standard of care communication and a group using an I phone intervention.
What is the current status of trial NCT01698008?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2012-01-28. Estimated completion is 2013-09-25.
What interventions are being tested in trial NCT01698008?
The interventions under investigation include: Diabetes Doctor Mobile app (OTHER).
Who is sponsoring clinical trial NCT01698008?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01698008's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI